Blackhawk Capital Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,900
Closed -$222K 94
2023
Q1
$222K Buy
+6,900
New +$222K 0.16% 81